Researchers at the University of California, Los Angeles (UCLA), in collaboration with pathologists from Hadassah Hebrew ...
The FDA designates ARB1002 as an orphan drug, highlighting its potential as a novel treatment for pancreatic cancer amid ...
Researchers found in mice that multiple nutrients and cancer cell characteristics work together to control the spread of ...
Professor Zhaohui Tang and Associate Professor Zhilin Liu from the team of Professor Xuesi Chen at the Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, developed ...
The Signatera assay showed positive correlations between ctDNA presence and cancer recurrence, suggesting its potential for ...
With durable responses, encouraging survival outcomes, and evidence that some patients may become eligible for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback